controversy about whether naproxen is safer in patients with heart disease than other NSAIDs

March 2014

You'll hear controversy about whether naproxen is safer in patients with heart disease than other NSAIDs.

All NSAIDs have a warning about increased CV risk. This was added almost a decade ago after the withdrawal of rofecoxib (Vioxx).

But CV risk isn't necessarily equal among NSAIDs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Colon Cancer more emphasis on improving colon cancer screening
Hypertension controversy about when it's acceptable to aim for HIGHER blood pressure goals
Interactions green tea may interfere with some meds
Respiratory & Allergy new sublingual tablet to treat seasonal allergic rhinitis called Grastek (GRASS-teck)
Poison Prevention Poisonings in kids due to PRESCRIPTION drugs are on the rise
Ophthalmology A new potent steroid eye drop called Durezol (DER-eh-zole, difluprednate 0.05%)
Women's Health what works to treat menopausal symptoms
Salt Forms how to choose between drugs that come in different salt forms
Drug Testing Questions often come up about urine drug testing
Med Safety best practices to further reduce some of the most serious medication errors
NSAIDs controversy about whether naproxen is safer in patients with heart disease than other NSAIDs